Document ID: chunk:federal_register_of_legislation:F2022L00906:reg:9:p3
Version: federal_register_of_legislation:F2022L00906
Segment Type: reg
Provision Reference: reg 9 (pt 3/3)
Character Range: 9483–10149

of obstructive sleep apnoea; or
(e)          taking protease inhibitors as antiretroviral drugs for human immunodeficiency virus infection before the clinical worsening of obstructive sleep apnoea;
Note: obstructive sleep apnoea is defined in the Schedule 1 - Dictionary.
(19)      for central sleep apnoea only, taking a long-acting opioid at an average daily morphine equivalent dose of at least 75 milligrams for at least the 2 months before the clinical worsening of central sleep apnoea;
Note: central sleep apnoea and long-acting opioid are defined in the Schedule 1 – Dictionary.
(20)      inability to obtain appropriate clinical management for sleep apnoea.